SKIN Stock Analysis: Buy, Sell, or Hold?

SKIN - The Beauty Health Company Class A Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$1.50
-0.01 (-0.66%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026

Get Alerted When SKIN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: SKIN shows positive signals but monitor for confirmation. Market pricing in 0.7% annual growth which appears achievable. Moderate conviction.

In-depth Analysis How we analyze

Valuation Analysis: SKIN is currently trading at $1.50, which is considered fair relative to its 30-day fair value range of $1.43 to $1.54. The stock's valuation (Forward PE: 10.0) is in line with its historical norms (9.8). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SKIN is in a downtrend. Immediate support is located at $1.44, while resistance sits at $1.58.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.96 (+30.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $1.43 - $1.54
Company Quality Score 58/100 (HOLD)
Options IV Signal 50th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 72.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Options fairly priced (IV 50th percentile)
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 30.6% below Wall St target ($1.96)
  • NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $1.43 - $1.54
Current vs Fair Value FAIR
Expected Move (7 Days) ±$0.24 (15.9%)

Support & Resistance Levels

Support Level $1.44
Resistance Level $1.58
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 10.00
Wall Street Target $1.96 (+30.6%)
Revenue Growth (YoY) -10.3%
Profit Margin -3.9%
Valuation Premium vs History +0.7% premium
PE vs Historical 10.0 vs 9.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.7% (market-implied from PE analysis)
1-Year Target $1.51 (+1%)
2-Year Target $1.52 (+1%)
3-Year Target $1.53 (+2%)
3-Yr Target (if PE normalizes) (PE: 10→10) PE COMPRESSION $1.50 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -6.3%) $2.76 (+84%)
Base: (SPY PE: 10.0, Growth: -6.3%) $1.24 (-18%)
Bear: (PE: 8.5, Growth: -6.3%) $1.05 (-30%)
Last updated: February 01, 2026 5:48 PM ET
Data refreshes hourly during market hours. Next update: 6:48 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Household & Personal Products Stocks

Top-rated stocks in Household & Personal Products by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
PG
Procter & Gamble Company
BUY
25 analysts
$167 67 BUY
CL
Colgate-Palmolive Company
BUY
22 analysts
$91 63 BUY
CHD
Church & Dwight Company …
HOLD
24 analysts
$97 61 BUY
ELF
ELF Beauty Inc
STRONG BUY
17 analysts
$113 52 HOLD
EL
Estee Lauder Companies I…
SELL
27 analysts
$110 55 HOLD

More Analysis for SKIN

SKIN Technical Chart SKIN Price Prediction SKIN Earnings Date SKIN Investment Advisor SKIN Fair Price Analyzer SKIN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals